Bringing a medical device to market requires navigating strict FDA regulations. Success depends on understanding which devices need approval, selecting the right regulatory pathway, and planning for every phase of development.
The FDA classifies devices by risk:
Approval involves more than ideation and design—it requires a complete lifecycle approach: research, prototyping, verification/validation, clinical studies (if needed), regulatory submission, FDA review, and post-market monitoring.
👉 Clearance vs. Approval:
The old Pre-IDE process is now the Q-Submission (Q-Sub) program. Companies can request feedback or a Pre-Sub meeting to align expectations before formal submission.
The FDA evaluates safety, efficacy, labeling, and quality systems. Once cleared or approved, commercialization can proceed under strict post-market compliance.
FDA approval or clearance requires more than a prototype—it demands strategy, evidence, and regulatory alignment. By identifying the correct pathway and engaging early with the FDA, companies can bring safe, effective devices to patients faster.
“Bioana team, you guys are simply amazing. Thanks so much for all your team’s hard work on this. We remain impressed beyond measure.”
Mark Lee
CEO, Ocumetics
"Our experience with Bioana had been outstanding. Their commitment, eye for detail, punctuality, proactivity and understanding manufacturing principles, workflow, quality and resourcefulness has been beyond our expectations."
Frank Harder
CRO , Bolb Inc.